Axsome CEO exercises options, sells 49,670 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Axsome Therapeutics, Inc. Chief Executive Officer Herriot Tabuteau exercised stock options that were nearing their 10-year expiration and sold the resulting 49,670 shares of common stock in open-market transactions at a weighted average price of $241.01 per share under a pre-approved Rule 10b5-1 plan. After these transactions, he holds 7,229 shares directly and 7,344,500 shares indirectly through an entity over which he has voting and dispositive power.
Insider Trade Summary 10b5-1
Exercise and Sale: 49,670 shares ($0.00 approx. pre-tax spread)
Exercise and Sale
4 txns
Insider
TABUTEAU HERRIOT
Role
Chief Executive Officer
Sold
49,670 shs ($11.97M)
Approx. gross sale proceeds
$11.97M
Approx. exercise cost
$11.97M
Approx. pre-tax spread
$0.00
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 49,670 | $0.00 | $0.00 |
| Exercise | Common Stock | 49,670 | $4.95 | $246K |
| Sale | Common Stock | 49,670 | $241.01 | $11.97M |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 99,330 contracts (Direct);
Common Stock — 7,229 shares (Direct);
Common Stock — 7,344,500 shares (Indirect, See Footnote)
Footnotes (5)
- F1. Necessary exercise of stock options set to expire due to attainment of the 10-year expiration date of such options.
- F2. Such transaction was pursuant to a pre-approved 10b5-1 plan.
- F3. Represents the subsequent sale of the underlying shares of the aforementioned exercise of stock options.
- F4. Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $236.11 and $244.13.
- F5. Such shares are held by an entity, of which the reporting person has voting and dispositive power, and therefore, the reporting person is deemed to be the indirect beneficial owner of such shares.
Key Figures
Shares sold: 49,670 shares
Weighted average sale price: $241.01 per share
Direct holdings after transaction: 7,229 shares
+2 more
5 metrics
Shares sold
49,670 shares
Open-market sale of common stock on 2026-06-09
Weighted average sale price
$241.01 per share
Open-market sales with prices from $236.11 to $244.13
Direct holdings after transaction
7,229 shares
Common stock held directly after 2026-06-09 transactions
Indirect holdings after transaction
7,344,500 shares
Common stock held indirectly via an entity after 2026-06-09
Options exercised
49,670 options
Stock options exercised into common shares due to 10-year expiration
Key Terms
pre-approved 10b5-1 plan, stock options, indirect beneficial owner, weighted average sale price
4 terms
pre-approved 10b5-1 plan financial
"Such transaction was pursuant to a pre-approved 10b5-1 plan."
stock options financial
"Necessary exercise of stock options set to expire due to attainment of the 10-year expiration date"
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
indirect beneficial owner financial
"the reporting person is deemed to be the indirect beneficial owner of such shares"
weighted average sale price financial
"Represents the weighted average sale price of a series of open market transactions"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Axsome Therapeutics (AXSM) report for its CEO?
Axsome Therapeutics reported that CEO Herriot Tabuteau exercised stock options that were approaching their 10-year expiration and sold the 49,670 underlying common shares in open-market transactions. These sales were executed pursuant to a pre-approved Rule 10b5-1 trading plan, indicating a scheduled liquidity event.
Were the Axsome (AXSM) CEO’s stock sales made under a Rule 10b5-1 plan?
Yes. A footnote explains that the stock sales were executed under a pre-approved Rule 10b5-1 plan. Such plans allow insiders to schedule trades in advance, helping separate routine portfolio management from discretionary, market-timed decisions about buying or selling company shares.
What type of Axsome (AXSM) security did the CEO exercise in this Form 4?
The CEO exercised stock options described as a “Stock Option (Right to Buy)” that entitled him to acquire 49,670 shares of Axsome common stock. A footnote states the exercise was necessary because the options were approaching their 10-year expiration date, prompting the conversion into shares.
What does the weighted average price in the Axsome (AXSM) CEO’s sale mean?
The weighted average sale price of $241.01 per share reflects a series of individual open-market trades. A footnote states that actual sale prices ranged from $236.11 to $244.13, with the average computed based on volumes and prices across those multiple transactions on the trade date.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates